New York State Common Retirement Fund Talis Biomedical Corp Transaction History

New York State Common Retirement Fund

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$0.81 - $1.44 $4,779 - $8,496	-5,900 Reduced 97.12%	175 $0
Q1 2022 May 05, 2022	BUY	$1.3 - $4.19 $40 - $129	31 Added 0.51%	6,075 $9,000
Q4 2021 Feb 02, 2022	SELL	$3.81 - $6.17 $118,380 - $191,708	-31,071 Reduced 83.72%	6,044 $24,000
Q3 2021 Nov 02, 2021	SELL	$6.02 - $12.46 $7,819 - $16,185	-1,299 Reduced 3.38%	37,115 $232,000
Q2 2021 Aug 02, 2021	SELL	$9.62 - $14.56 $10,957 - $16,583	-1,139 Reduced 2.88%	38,414 $424,000
Q1 2021 May 11, 2021	BUY	$11.2 - $27.8 $442,993 - $1.1 Million	39,553 New	39,553 $508,000

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $47.6M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.